185 related articles for article (PubMed ID: 15265495)
1. Novel 18beta-glycyrrhetinic acid analogues as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenases.
Su X; Lawrence H; Ganeshapillai D; Cruttenden A; Purohit A; Reed MJ; Vicker N; Potter BV
Bioorg Med Chem; 2004 Aug; 12(16):4439-57. PubMed ID: 15265495
[TBL] [Abstract][Full Text] [Related]
2. A novel 18 beta-glycyrrhetinic acid analogue as a potent and selective inhibitor of 11 beta-hydroxysteroid dehydrogenase 2.
Vicker N; Su X; Lawrence H; Cruttenden A; Purohit A; Reed MJ; Potter BV
Bioorg Med Chem Lett; 2004 Jun; 14(12):3263-7. PubMed ID: 15149687
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
Stanetty C; Czollner L; Koller I; Shah P; Gaware R; Cunha TD; Odermatt A; Jordis U; Kosma P; Classen-Houben D
Bioorg Med Chem; 2010 Nov; 18(21):7522-41. PubMed ID: 20851614
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
Gaware R; Khunt R; Czollner L; Stanetty C; Da Cunha T; Kratschmar DV; Odermatt A; Kosma P; Jordis U; Classen-Houben D
Bioorg Med Chem; 2011 Mar; 19(6):1866-80. PubMed ID: 21376605
[TBL] [Abstract][Full Text] [Related]
5. Effects of glycyrrhetinic acid derivatives on hepatic and renal 11beta-hydroxysteroid dehydrogenase activities in rats.
Shimoyama Y; Hirabayashi K; Matsumoto H; Sato T; Shibata S; Inoue H
J Pharm Pharmacol; 2003 Jun; 55(6):811-7. PubMed ID: 12841942
[TBL] [Abstract][Full Text] [Related]
6. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
Roche D; Carniato D; Leriche C; Lepifre F; Christmann-Franck S; Graedler U; Charon C; Bozec S; Doare L; Schmidlin F; Lecomte M; Valeur E
Bioorg Med Chem Lett; 2009 May; 19(10):2674-8. PubMed ID: 19395260
[TBL] [Abstract][Full Text] [Related]
7. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds.
Blum A; Favia AD; Maser E
Mol Cell Endocrinol; 2009 Mar; 301(1-2):132-6. PubMed ID: 18822345
[TBL] [Abstract][Full Text] [Related]
8. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of 11beta-hydroxysteroid dehydrogenase 1 by 18alpha-glycyrrhetinic acid but not 18beta-glycyrrhetinic acid.
Classen-Houben D; Schuster D; Da Cunha T; Odermatt A; Wolber G; Jordis U; Kueenburg B
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):248-52. PubMed ID: 19429429
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human and rat 11beta-hydroxysteroid dehydrogenase type 1 by 18beta-glycyrrhetinic acid derivatives.
Su X; Vicker N; Lawrence H; Smith A; Purohit A; Reed MJ; Potter BV
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):312-20. PubMed ID: 17493801
[TBL] [Abstract][Full Text] [Related]
11. Mono-carbonyl curcumin analogues as 11β-hydroxysteroid dehydrogenase 1 inhibitors.
Lin H; Hu GX; Guo J; Ge Y; Liang G; Lian QQ; Chu Y; Yuan X; Huang P; Ge RS
Bioorg Med Chem Lett; 2013 Aug; 23(15):4362-6. PubMed ID: 23800686
[TBL] [Abstract][Full Text] [Related]
12. 3-Monoglucuronyl-glycyrrhretinic acid is a substrate of organic anion transporters expressed in tubular epithelial cells and plays important roles in licorice-induced pseudoaldosteronism by inhibiting 11β-hydroxysteroid dehydrogenase 2.
Makino T; Okajima K; Uebayashi R; Ohtake N; Inoue K; Mizukami H
J Pharmacol Exp Ther; 2012 Aug; 342(2):297-304. PubMed ID: 22543032
[TBL] [Abstract][Full Text] [Related]
13. The synthesis of 18beta-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells.
Liu D; Song D; Guo G; Wang R; Lv J; Jing Y; Zhao L
Bioorg Med Chem; 2007 Aug; 15(16):5432-9. PubMed ID: 17566745
[TBL] [Abstract][Full Text] [Related]
14. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
Kasuya Y; Yokokawa A; Takashima S; Shibasaki H; Furuta T
Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
[TBL] [Abstract][Full Text] [Related]
15. Microbial transformation of 18beta-glycyrrhetinic acid by Cunninghamella elegans and Fusarium lini, and lipoxygenase inhibitory activity of transformed products.
Iqbal Choudhary M; Ali Siddiqui Z; Ahmed Nawaz S
Nat Prod Res; 2009; 23(6):507-13. PubMed ID: 19384727
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 by docking and pharmacophore modeling.
Yang H; Dou W; Lou J; Leng Y; Shen J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1340-5. PubMed ID: 18242087
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase.
Cheng K; Liu J; Sun H; Xie J
Chem Biodivers; 2010 Mar; 7(3):690-7. PubMed ID: 20232331
[TBL] [Abstract][Full Text] [Related]
18. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
Latif SA; Pardo HA; Hardy MP; Morris DJ
Mol Cell Endocrinol; 2005 Nov; 243(1-2):43-50. PubMed ID: 16188377
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.
Beseda I; Czollner L; Shah PS; Khunt R; Gaware R; Kosma P; Stanetty C; Del Ruiz-Ruiz MC; Amer H; Mereiter K; Da Cunha T; Odermatt A; Classen-Houben D; Jordis U
Bioorg Med Chem; 2010 Jan; 18(1):433-54. PubMed ID: 19914836
[TBL] [Abstract][Full Text] [Related]
20. Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors.
Webster SP; Ward P; Binnie M; Craigie E; McConnell KM; Sooy K; Vinter A; Seckl JR; Walker BR
Bioorg Med Chem Lett; 2007 May; 17(10):2838-43. PubMed ID: 17350260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
